Addleshaws wants no part of the Anti-Growth Coalition
One firm’s growth is only on the up
Financials 2019/20: Addleshaws to hold back 5 per cent of partner profits
Addleshaw Goddard’s average profit per equity partner fell 4 per cent over 2019/20, with the firm directing a small proportion of its profits into an investment reserve to stem the blow of Covid-19. The firm announced today that global revenue rose 4 per cent from £275m to £288m despite saying that Covid-19 has had “an […]
Judgments of Note: Neurim Pharmaceuticals, Prosecco and GSK
Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t/a Mylan) & Anor [2020] EWCA Civ 793 (24 June 2020) The Court of Appeal unanimously upheld the decision of the Patents Court to refuse an interim injunction in a pharmaceutical patent case. The High Court heard the appeal on as expedited basis through a […]